The real risk of nodal disease in T1 oesophageal adenocarcinoma-Reference-Cited by-同舟云学术

The real risk of nodal disease in T1 oesophageal adenocarcinoma

Published:2020-02-17 Issue:3 Volume:52 Page:110-117
ISSN:1682-8631
Container-title:European Surgery
language:en
Short-container-title:Eur Surg

Author:

Mitchell David P.,Yeluri Sashi,Van der Wall Hans,Falk Gregory L.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10353-019-00627-x.pdf

Reference47 articles.

1. Ajani JA, et al. Esophageal and Esophagogastric Junction Cancers, version2.2019, NCCNClinical Practice Guidelines in oncology. J Natl Compr Canc Netw. 2019;17(7):855–883

2. Chadwick G, Varagunam M, Brand C, et al. National Oesophag-Gastric Cancer Audit. An Audit of the care received by people with Oesophago-Gastric Cancer in England and Wales. Ninth Annual Report 2016. L.N.I. Centre; 2016.

3. Nobel T, et al. Ongoing challenges with clinical assessment of nodal status in T1 esophageal adenocarcinoma. J Am Coll Surg. 2018;229(4):366–73.

4. van Hagen P, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074–84.

5. Cunningham D, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11–20.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors for lymph node metastasis and survival of patients with T1b esophageal adenocarcinoma treated with surgery and endoscopic therapy: an analysis of the Surveillance, Epidemiology, and End Results database;Gastrointestinal Endoscopy;2024-05

2. Risk of lymph node metastasis in T1 esophageal adenocarcinoma: a meta-analysis;Diseases of the Esophagus;2024-02-22

3. Microvascular myocutaneous and cutaneous free flap reconstruction in patients with terminal esophagostomy after complicated oncological esophagus resection;European Surgery;2021-12-23

4. Estimating risk of metastatic disease in T1b esophageal adenocarcinoma: incremental progress but gaps remain;Endoscopy;2021-08-17

5. Programmed death ligand 2 expression plays a limited role in adenocarcinomas of the gastroesophageal junction after preoperative chemotherapy;European Surgery;2021-05-05